Biocon and Equillium initiate Clinical Study for Itolizumab in India, Health News, ET HealthWorld
Bengaluru : US-based Equillium Inc., Biocon’s partner, has expanded its EQUALISE study in Systemic Lupus Erythematosus (SLE) and Lupus Nephritis for Itolizumab (ALZUMAb-L) to clinical centers in India. EQUALISE is…
